Global Synthetic Biology Technology In Healthcare Market Growth (Status and Outlook) 2025-2031

The global Synthetic Biology Technology In Healthcare market size is predicted to grow from US$ 5464 million in 2025 to US$ 10860 million in 2031; it is expected to grow at a CAGR of 12.1% from 2025 to 2031.

Synthetic biology technology in healthcare refers to the use of principles and methods of synthetic biology to design and construct new biological components, systems, or machines to improve the overall effectiveness of healthcare and disease treatment. Synthetic biology techniques in healthcare typically include gene editing technology, metabolic engineering, cell factory design, synthetic genomics, and other fields, mainly applied in drug development, vaccine design and production, gene therapy, cell therapy, microecological therapy, and other areas.

The synthetic biology technology market in healthcare has maintained a growth trend in recent years. The application of synthetic biology technology in the development of biosimilars and personalized drugs is particularly prominent. With the maturity of gene editing technology, synthetic biology technology has rapidly developed in gene therapy and cell therapy, becoming an important driving force in the field of healthcare. In addition, biosensors and diagnostic tools based on synthetic biology technology are driving the development of precision medicine. The main market participants include multinational pharmaceutical companies such as Pfizer, Merck, and Johnson&Johnson, which have deep technological accumulation and market influence in the biopharmaceutical field, biotechnology companies such as Ginkgo Bioworks and Amyris, which focus on using synthetic biology technology to produce high value-added products, and Chinese companies such as BGI Genomics and BeiGene achieving results in gene editing and drug development. In the future, breakthroughs in technologies such as gene editing and high-throughput screening will further promote the application of synthetic biology in healthcare. Governments of various countries will continue to increase their policy support and funding investment in synthetic biology technology, providing strong guarantees for the development of the industry. The application of synthetic biology technology in healthcare is reshaping the industry landscape, and its efficient, precise, and sustainable features will provide more new solutions for drug development, disease treatment, and diagnosis.

LPI (LP Information)' newest research report, the “Synthetic Biology Technology In Healthcare Industry Forecast” looks at past sales and reviews total world Synthetic Biology Technology In Healthcare sales in 2024, providing a comprehensive analysis by region and market sector of projected Synthetic Biology Technology In Healthcare sales for 2025 through 2031. With Synthetic Biology Technology In Healthcare sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Synthetic Biology Technology In Healthcare industry.

This Insight Report provides a comprehensive analysis of the global Synthetic Biology Technology In Healthcare landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Synthetic Biology Technology In Healthcare portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Synthetic Biology Technology In Healthcare market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Synthetic Biology Technology In Healthcare and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Synthetic Biology Technology In Healthcare.

This report presents a comprehensive overview, market shares, and growth opportunities of Synthetic Biology Technology In Healthcare market by product type, application, key players and key regions and countries.

Segmentation by Type:
Gene Editing Technology
Metabolic Engineering
Cell Factory Design
Synthetic Genomics
Others

Segmentation by Application:
Drug Development
Vaccine Design And Production
Gene Therapy
Cellular Immunotherapy
Microecological Therapy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Merck
Johnson & Johnson
Anthem Biosciences
Genomatica
Illumina
Synthetic Genomics
Ginkgo Bioworks
Novozymes
Amyris
Codexis
Precigen
Moderna Therapeutics
BGI Genomics
BeiGene
Shandong Lukang Pharmaceutical
Asymchem Laboratories
Cathay Biotech
HuaHao Tiancheng Biotechnology
Vland Biotech Group
Hybio Pharmaceutical
Huadong Medicine
WOTE Advanced Materials
Hainan Poly Pharm
Shandong Xinhua Pharmaceutical

Please note: The report will take approximately 2 business days to prepare and deliver. Show more